Journal Article10.1016/J.CANLET.2004.06.014
Cyclooxygenases in cancer: progress and perspective.
407
TL;DR: The rapid development of safe and effective inhibitors targeting individual COX enzymes not only dramatically improved the understanding of the function of COX-2, but also resulted in discovery ofCOX independent functions of NSAIDs, providing important hints for future drug design.
read more
About: This article is published in Cancer Letters. The article was published on 08 Nov 2004. The article focuses on the topics: Mouse model of colorectal and intestinal cancer & Cancer.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Data from Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma
31 Mar 2023
TL;DR: In this article , copy number alterations (CNA) in premalignant tissues have been well characterized or evaluated in cohort studies as biomarkers of cancer risk, including DNA content aneuploidy, loss of heterozygosity, and comparative genomic hybridization.
LIPID MEDIATORS | Prostanoids
M. Peters-Golden
- 01 Jan 2006
TL;DR: Either overproduction or underproduction of prostanoids has been implicated in a variety of lung diseases, including asthma, interstitial lung disease, pulmonary vascular disease, cancer, and infections.
Gene-gene and gene-environment interactions in prostate, breast and colorectal cancer
Tine Iskov Kopp
- 01 Jan 2015
TL;DR: This study did not indicate that chronic inflammation is a major risk factor for aggressive PC, but inborn variations in genes involved in the inflammatory response may modulate the risk of PC and interact with NSAIDs.
Data from PGE<sub>2</sub>-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
Jin Cao
- 30 Mar 2023
TL;DR: In this article , the tumor-associated inflammatory mediator prostaglandin E (PGE) was found to attract myeloid-derived suppressor cells (MDSC) into the ascites microenvironment.
References
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
TL;DR: Experiments with guinea-pig lung suggest that some of the therapeutic effects of sodium salicylate and aspirin-like drugs are due to inhibition of the synthesis of prostaglandins.
8.8K
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
TL;DR: Important insights into the mechanisms of inflammatory responses, pain, and fever have been gleaned from the current understanding of eicosanoid biology.
3.8K
Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation
TL;DR: Leukotrienes C4, D4, and E4, which are released from the lung tissue of asthmatic subjects exposed to specific allergens, seem to play a pathophysiological role in immediate hypersensitivity reactions.
2.8K
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Charles E. Eberhart,Robert J. Coffey,Aramandla Radhika,Francis M. Giardiello,Suzanne Ferrenbach,Raymond N. DuBois +5 more
TL;DR: COX-2, but not COX-1, gene expression is markedly elevated in most human colorectal cancers compared with accompanying normal mucosa, and COx-2 expression seems to be increased in a subset of adenomas.
2.6K
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Gideon Steinbach,Patrick M. Lynch,R. K. S. Phillips,Marina Wallace,Ernest T. Hawk,Gary Gordon,Naoki Wakabayashi,Brian D. Saunders,Yu Shen,Takashi Fujimura,Li Kuo Su,Bernard Levin,Louis Godio,Sherri Patterson,Miguel A. Rodriguez-Bigas,Susan L. Jester,Karen L. King,Marta Schumacher,James L. Abbruzzese,Raymond N. DuBois,Walter N. Hittelman,Stuart O. Zimmerman,Jeffrey W. Sherman,Gary J. Kelloff +23 more
TL;DR: In patients with familial adenomatous polyposis, six months of twice-daily treatment with 400 mg of celecoxib, a cyclooxygenase-2 inhibitor, leads to a significant reduction in the number of colorectal polyps.
2.6K